24 results
8-K
EX-10.2
CNSP
Cns Pharmaceuticals Inc
2 Feb 24
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-10.1
CNSP
Cns Pharmaceuticals Inc
2 Feb 24
Entry into a Material Definitive Agreement
5:00pm
S-1
EX-10.22
CNSP
Cns Pharmaceuticals Inc
IPO registration
8 Dec 23
5:28pm
8-K
EX-10.1
CNSP
Cns Pharmaceuticals Inc
17 Oct 23
Entry into a Material Definitive Agreement
8:00am
8-K
EX-10.1
yvu yzjlthdn
18 Sep 23
Submission of Matters to a Vote of Security Holders
7:51pm
8-K
EX-10.1
v3nxbd6c
1 Dec 22
CNS Pharmaceuticals Announces Pricing of $6.0 Million Public Offering At a Premium to the Market Closing Price
5:19pm
8-K
EX-10.3
59acl2zmifz3u8l
1 Dec 22
CNS Pharmaceuticals Announces Pricing of $6.0 Million Public Offering At a Premium to the Market Closing Price
5:19pm
8-K
EX-10.2
cvoyur32f 1ov
1 Dec 22
CNS Pharmaceuticals Announces Pricing of $6.0 Million Public Offering At a Premium to the Market Closing Price
5:19pm
8-K
EX-10.2
2i62h5
6 Jan 22
CNS Pharmaceuticals Announces $11.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
9:11am
8-K
EX-10.1
ovhmeo0mf
6 Jan 22
CNS Pharmaceuticals Announces $11.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
9:11am
8-K
EX-10.3
49es3f8l8r ur6r350u
6 Jan 22
CNS Pharmaceuticals Announces $11.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
9:11am
8-K
EX-10.1
yke b93ox
21 Sep 20
Entry into a Material Definitive Agreement
8:03am
8-K
EX-10.2
mtfxynbwi8
21 Sep 20
Entry into a Material Definitive Agreement
8:03am
8-K
EX-10.1
aybis qbi
26 Mar 20
Entry into a Material Definitive Agreement
4:30pm
10-K
EX-10.11
xhu8e gv00
12 Mar 20
Annual report
4:06pm